1. Home
  2. PDSB vs REFR Comparison

PDSB vs REFR Comparison

Compare PDSB & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • REFR
  • Stock Information
  • Founded
  • PDSB 2005
  • REFR 1965
  • Country
  • PDSB United States
  • REFR United States
  • Employees
  • PDSB N/A
  • REFR N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • REFR Multi-Sector Companies
  • Sector
  • PDSB Health Care
  • REFR Miscellaneous
  • Exchange
  • PDSB Nasdaq
  • REFR Nasdaq
  • Market Cap
  • PDSB 58.7M
  • REFR 48.3M
  • IPO Year
  • PDSB N/A
  • REFR N/A
  • Fundamental
  • Price
  • PDSB $1.34
  • REFR $1.21
  • Analyst Decision
  • PDSB Strong Buy
  • REFR
  • Analyst Count
  • PDSB 3
  • REFR 0
  • Target Price
  • PDSB $14.00
  • REFR N/A
  • AVG Volume (30 Days)
  • PDSB 1.3M
  • REFR 30.7K
  • Earning Date
  • PDSB 05-14-2025
  • REFR 03-06-2025
  • Dividend Yield
  • PDSB N/A
  • REFR N/A
  • EPS Growth
  • PDSB N/A
  • REFR N/A
  • EPS
  • PDSB N/A
  • REFR N/A
  • Revenue
  • PDSB N/A
  • REFR $1,335,531.00
  • Revenue This Year
  • PDSB $5,518.68
  • REFR N/A
  • Revenue Next Year
  • PDSB N/A
  • REFR N/A
  • P/E Ratio
  • PDSB N/A
  • REFR N/A
  • Revenue Growth
  • PDSB N/A
  • REFR 46.83
  • 52 Week Low
  • PDSB $1.13
  • REFR $1.10
  • 52 Week High
  • PDSB $4.92
  • REFR $2.41
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 50.27
  • REFR 38.51
  • Support Level
  • PDSB $1.30
  • REFR $1.10
  • Resistance Level
  • PDSB $1.41
  • REFR $1.42
  • Average True Range (ATR)
  • PDSB 0.10
  • REFR 0.08
  • MACD
  • PDSB 0.02
  • REFR -0.00
  • Stochastic Oscillator
  • PDSB 60.61
  • REFR 31.43

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.

Share on Social Networks: